Register for Your Free On-Demand Webinar Now:

"The Value of Early Real-World Data in Clinical and Commercial Strategy"

Explore how GSK leveraged early investment in claims data to de-risk drug development and improve commercial decision-making.

In pharmaceutical development, where most therapies never reach the market, early and strategic data investments can make all the difference. Teams are often challenged by minimal budgets and limited visibility into the real-world treatment landscape - especially in therapeutic areas where the organization has limited prior experience or knowledge.

In this webinar, experts share how their team transformed early development by using claims data to reduce risk, uncover real-world treatment dynamics, and improve evidence generation ahead of launch. You'll hear how they shifted from data scarcity to insight-driven decision making - improving alignment across clinical, medical, and commercial functions. Key takeaways will include:

• How they modernized early-stage evidence generation with real-world claims data
• Strategies for securing budget and cross-functional buy-in
• Practical “levers for success” you can apply within your own teams

Offered Free by: BioPharma Dive's studioID and PurpleLab
See All Resources from: BioPharma Dive's studioID and PurpleLab